BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Astrocytoma AND Ki-67 AND Prognosis
143 results:

  • 1. DKK3 Expression in Glioblastoma: Correlations with Biomolecular Markers.
    Caffo M; Casili G; Caruso G; Barresi V; Campolo M; Paterniti I; Minutoli L; Ius T; Esposito E
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612910
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A novel grading system combining histological grade and CDKN2A homozygous and hemizygous deletion to predict prognosis in IDH-mutant astrocytoma.
    Xi S; Huang Q; Zeng J
    J Neuropathol Exp Neurol; 2024 Jan; 83(2):125-130. PubMed ID: 38175671
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A validated prognostic nomogram for patients with H3 K27M-mutant diffuse midline glioma.
    Peng Y; Ren Y; Huang B; Tang J; Jv Y; Mao Q; Liu Y; Lei Y; Zhang Y
    Sci Rep; 2023 Jun; 13(1):9970. PubMed ID: 37340065
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Characterization and clinical implications of different malignant transformation patterns in diffuse low-grade gliomas.
    Jiang H; Zhu Q; Wang X; Li M; Shen S; Yang C; Zhao X; Li M; Ma G; Zhao X; Chen X; Yang J; Lin S
    Cancer Sci; 2023 Sep; 114(9):3708-3718. PubMed ID: 37332121
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Low expression of ki-67/MIB-1 labeling index in IDH wild type glioblastoma predicts prolonged survival independently by MGMT methylation status.
    Tini P; Yavoroska M; Mazzei MA; Miracco C; Pirtoli L; Tomaciello M; Marampon F; Minniti G
    J Neurooncol; 2023 Jun; 163(2):339-344. PubMed ID: 37227648
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Prediction of ki-67 labeling index, ATRX mutation, and MGMT promoter methylation status in IDH-mutant astrocytoma by morphological MRI, SWI, DWI, and DSC-PWI.
    Yang X; Hu C; Xing Z; Lin Y; Su Y; Wang X; Cao D
    Eur Radiol; 2023 Oct; 33(10):7003-7014. PubMed ID: 37133522
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker.
    Martínez-Bosch N; Vilariño N; Alameda F; Mojal S; Arumí-Uria M; Carrato C; Aldecoa I; Ribalta T; Vidal N; Bellosillo B; Menéndez S; Del Barco S; Gallego O; Pineda E; López-Martos R; Hernández A; Mesia C; Esteve-Codina A; de la Iglesia N; Balañá C; Martínez-García M; Navarro P
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980184
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Diffuse midline glioma with H3K27 alteration in adults: a clinicopathological analysis].
    Yang QY; Li MN; Chen TY; Liu C; Li X; Shi ZM; Pan MH
    Zhonghua Bing Li Xue Za Zhi; 2023 Apr; 52(4):376-383. PubMed ID: 36973199
    [No Abstract]    [Full Text] [Related]  

  • 9. Prognostic Factors of Gliosarcoma in the Real World: A Retrospective Cohort Study.
    Yu Z; Zhou Z; Xu M; Song K; Shen J; Zhu W; Wei L; Xu H
    Comput Math Methods Med; 2023; 2023():1553408. PubMed ID: 36756387
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Genomic profiling and prognostic factors of H3 K27M-mutant spinal cord diffuse glioma.
    Chai RC; Yan H; An SY; Pang B; Chen HY; Mu QH; Zhang KN; Zhang YW; Liu YQ; Liu X; Zhao Z; Jiang T; Wang YZ; Jia WQ
    Brain Pathol; 2023 Jul; 33(4):e13153. PubMed ID: 36751054
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. An integrative non-invasive malignant brain tumors classification and ki-67 labeling index prediction pipeline with radiomics approach.
    Zhang L; Liu X; Xu X; Liu W; Jia Y; Chen W; Fu X; Li Q; Sun X; Zhang Y; Shu S; Zhang X; Xiang R; Chen H; Sun P; Geng D; Yu Z; Liu J; Wang J
    Eur J Radiol; 2023 Jan; 158():110639. PubMed ID: 36463703
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Timing of radiotherapy in glioblastoma based on IMRT and STUPP chemo-radiation: may be no need to rush.
    Li S; Guo F; Wang X; Zeng J; Hong J
    Clin Transl Oncol; 2022 Nov; 24(11):2146-2154. PubMed ID: 35753023
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Distribution and favorable prognostic implication of genomic EGFR alterations in IDH-wildtype glioblastoma.
    Higa N; Akahane T; Hamada T; Yonezawa H; Uchida H; Makino R; Watanabe S; Takajo T; Yokoyama S; Kirishima M; Matsuo K; Fujio S; Hanaya R; Tanimoto A; Yoshimoto K
    Cancer Med; 2023 Jan; 12(1):49-60. PubMed ID: 35695190
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Monocentric evaluation of ki-67 labeling index in combination with a modified RPA score as a prognostic factor for survival in IDH-wildtype glioblastoma patients treated with radiochemotherapy.
    Dumke R; Dumke C; Eberle F; Nimsky C; Keber U; Engenhart-Cabillic R; Lautenschläger S
    Strahlenther Onkol; 2022 Oct; 198(10):892-906. PubMed ID: 35612598
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Anaplastic pleomorphic xanthoastrocytoma - single-center analysis of 42 patients].
    Belyaev AY; Shugai SV; Kobyakov GL; Strunina YV; Batalov AI; Pronin IN; Usachev DY
    Zh Vopr Neirokhir Im N N Burdenko; 2022; 86(2):45-54. PubMed ID: 35412712
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Genetic and histopathological associations with outcome in pediatric pilocytic astrocytoma.
    Cler SJ; Skidmore A; Yahanda AT; Mackey K; Rubin JB; Cluster A; Perkins S; Gauvain K; King AA; Limbrick DD; McEvoy S; Park TS; Smyth MD; Mian AY; Chicoine MR; Dahiya S; Strahle JM
    J Neurosurg Pediatr; 2022 May; 29(5):504-512. PubMed ID: 35148515
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Molecular features of glioblastomas in long-term survivors compared to short-term survivors-a matched-pair analysis.
    Sommerlath VN; Buergy D; Etminan N; Brehmer S; Reuss D; Sarria GR; Guiot MC; Hänggi D; Wenz F; Petrecca K; Giordano FA
    Radiat Oncol; 2022 Jan; 17(1):15. PubMed ID: 35073955
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Radiologic-pathologic association of tumor-like lesions with inflammation in cerebral white matter: Comparison of two cases with distinct clinical outcomes.
    Shishido-Hara Y; Akazawa K; Takeuchi H; Hirato J; Konishi E; Yamada K; Itoh K; Hashimoto N
    Neuropathology; 2021 Dec; 41(6):468-475. PubMed ID: 34791710
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Association of GMF-β expression with ki-67 and its significance in the prognostic evaluation of astrocytoma].
    Kuang XY; Xu SL; Cui W; Jiang XF
    Zhonghua Bing Li Xue Za Zhi; 2021 Nov; 50(11):1252-1256. PubMed ID: 34719163
    [No Abstract]    [Full Text] [Related]  

  • 20. Establishment and Validation of the Detection of TERT Promoter Mutations by Human Gliomas U251 Cell Lines.
    Bai H; Bai S; Li X; Zhang Y; Li Y; He F; Cheng W
    Biomed Res Int; 2021; 2021():3271395. PubMed ID: 34159191
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 8.